Corrigendum: Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular

Siyu Zhang1, Changxin Huang1, Yongqiang Li1

  • 1Department of Oncology, Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.

Frontiers in Immunology
|December 18, 2024
PubMed

Insights

This study corrects a previously published article DOI. The correction ensures accurate citation and retrieval of important scientific findings in immunology research.

Area of Science:

  • Immunology
  • Scientific Publishing

Context:

  • Correction of a published article DOI.
  • Ensuring accurate scientific record-keeping.

Purpose:

  • To amend the Digital Object Identifier (DOI) for a specific publication.
  • To facilitate correct referencing and access to research.

Summary:

  • The article DOI 10.3389/fimmu.2024.1473145 has been corrected.
  • This ensures the integrity of the scientific literature.

Impact:

  • Improved discoverability of the corrected article.
  • Enhanced reliability of scientific citations and data retrieval.

Related Concept Videos